Found: 34
Select item for more details and to access through your institution.
Analysis of stem cell collections in adult patients with Ewing sarcoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6131, doi. 10.1007/s00432-023-04587-4
- By:
- Publication type:
- Article
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3739, doi. 10.1007/s00432-022-04184-x
- By:
- Publication type:
- Article
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 10, p. 3081, doi. 10.1007/s00432-021-03569-8
- By:
- Publication type:
- Article
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2349, doi. 10.1007/s00432-020-03504-3
- By:
- Publication type:
- Article
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1645, doi. 10.1007/s00432-019-02910-6
- By:
- Publication type:
- Article
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 1, p. 317, doi. 10.1007/s00432-015-2050-y
- By:
- Publication type:
- Article
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 11, p. 2013, doi. 10.1007/s00432-015-1984-4
- By:
- Publication type:
- Article
Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F‐ and MPLW515 L‐positive myelofibrosis.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 11, p. 747, doi. 10.1002/gcc.22781
- By:
- Publication type:
- Article
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. E382, doi. 10.1002/ajh.26653
- By:
- Publication type:
- Article
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. 1287, doi. 10.1002/ajh.26298
- By:
- Publication type:
- Article
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1569, doi. 10.1007/s00277-024-05702-2
- By:
- Publication type:
- Article
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2741, doi. 10.1007/s00277-023-05394-0
- By:
- Publication type:
- Article
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Implications of the FLT3 -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1312, doi. 10.3390/cancers15041312
- By:
- Publication type:
- Article
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5679, doi. 10.3390/cancers13225679
- By:
- Publication type:
- Article
Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.775313
- By:
- Publication type:
- Article
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.749691
- By:
- Publication type:
- Article
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.737645
- By:
- Publication type:
- Article
Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplant.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1163107
- By:
- Publication type:
- Article
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. e277, doi. 10.1016/j.clml.2024.05.006
- By:
- Publication type:
- Article
P-185: Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 myeloma patients: a retrospective real-world study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S138, doi. 10.1016/S2152-2650(21)02312-0
- By:
- Publication type:
- Article
Extramedullary Clonal Hematopoiesis with Indeterminate Potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e696, doi. 10.1016/j.clml.2021.04.008
- By:
- Publication type:
- Article
Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. e579, doi. 10.1016/j.clml.2021.02.008
- By:
- Publication type:
- Article
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00764-9
- By:
- Publication type:
- Article
Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma.
- Published in:
- Transfusion, 2023, v. 63, n. 11, p. 2131, doi. 10.1111/trf.17566
- By:
- Publication type:
- Article
Comparison of non‐myeloablative and reduced‐intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1344, doi. 10.1002/ajh.25636
- By:
- Publication type:
- Article
Prognostic impact of the CD34+/CD38− cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 388, doi. 10.1002/ajh.24663
- By:
- Publication type:
- Article
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2024, v. 147, n. 3, p. 344, doi. 10.1159/000533666
- By:
- Publication type:
- Article
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 3, p. 217, doi. 10.1159/000501927
- By:
- Publication type:
- Article
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01746
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00219
- By:
- Publication type:
- Article